The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.